Page 1213 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

4 References

aneurysm in the International Subarachnoid Aneurysm Trial 101. Miller JA, Dacey RG, Diringer MN. Safety of hypertensive
(ISAT): long-term follow-up. Lancet Neurol. 2009;8:427-433. hypervolemic therapy with phenylephrine in the treatment
93. Solenski NJ, Haley EC, Kassell NF, et al. Medical complica- of delayed ischemic deficits after subarachnoid hemorrhage.
tions of aneurysmal subarachnoid hemorrhage: a report of Stroke. 1995;26:2260-2266.
the multicenter, cooperative aneurysm study. Participants 102. Findlay JM, Kassell NF, Weir BK, et al. A randomized trial of
of the Multicenter Cooperative Aneurysm Study. Critical Care intraoperative, intracisternal tissue plasminogen activator for
Medicine. 1995;23:1007-1017. the prevention of vasospasm. Neurosurgery. 1995;37:168-176.
94. Macmillan CSA, Grant IS, Andrews PJD. Pulmonary and car- 103. Haley EC, Kassell NF, Alves WM, Weir BK, Hansen CA. Phase
diac sequelae of subarachnoid haemorrhage: time for active II trial of tirilazad in aneurysmal subarachnoid hemorrhage.
management? Intensive Care Medicine. 2002;28:1012-1023. A report of the Cooperative Aneurysm Study. J Neurosurg.
95. Diringer MN. Neuroendocrine regulation of sodium and volume 1995;82:786-790.
following subarachnoid hemorrhage. Clin Neuropharmacol. 104. Haley EC, Kassell NF, Apperson-Hansen C, Maile MH, Alves
1995;18:114-126. WM. A randomized, double-blind, vehicle-controlled trial
96. Jordan JD, Nyquist P. Biomarkers and vasospasm after aneu- of tirilazad mesylate in patients with aneurysmal subarach-
rysmal subarachnoid hemorrhage. Neurosurg Clin N Am. noid hemorrhage: a cooperative study in North America.
2010;21:381-391. J Neurosurg. 1997;86:467-474.
97. Marshall SA, Nyquist P, Ziai WC. The role of transcranial 105. Asano T, Takakura K, Sano K, et al. Effects of a hydroxyl radical
Doppler ultrasonography in the diagnosis and management scavenger on delayed ischemic neurological deficits following
of vasospasm after aneurysmal subarachnoid hemorrhage. aneurysmal subarachnoid hemorrhage: results of a multicenter,
Neurosurg Clin N Am. 2010;21:291-303. placebo-controlled double-blind trial. J Neurosurg. 1996;84:792-803.
98. Greenberg ED, Gold R, Reichman M, et al. Diagnostic accuracy 106. Saito I, Asano T, Sano K, et al. Neuroprotective effect of an
of CT angiography and CT perfusion for cerebral vasospasm: a antioxidant, ebselen, in patients with delayed neurological defi-
meta-analysis. AJNR Am J Neuroradiol. 2010;31(10):1853-1860. cits after aneurysmal subarachnoid hemorrhage. Neurosurgery.
1998;42:269-277.
99. Joseph M, Ziadi S, Nates J, Dannenbaum M, Malkoff M.
Increases in cardiac output can reverse flow deficits from 107. Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to
vasospasm independent of blood pressure: a study using xenon overcome neurological ischemia and infarction occurring after
computed tomographic measurement of cerebral blood flow. subarachnoid hemorrhage (CONSCIOUS-1): randomized,
Neurosurgery. 2003;53:1044-1051. double-blind, placebo-controlled phase 2 dose-finding trial.
Stroke. 2008;39:3015-3021.
100. Mutoh T, Kazumata K, Ishikawa T, Terasaka S. Performance
of bedside transpulmonary thermodilution monitoring for 108. Rabinstein AA, Lanzino G, Wijdicks EF. Multidisciplinary man-
goal-directed hemodynamic management after subarachnoid agement and emerging therapeutic strategies in aneurysmal
hemorrhage. Stroke. 2009;40:2368-2374. subarachnoid haemorrhage. Lancet Neurol. 2010;9:504-519.

Section06-O-ref.indd 4 12/10/2014 6:03:38 PM